Stock Events

Stock Events

Tscan Therapeutics (TCRX) Q3 2024 Earnings

12AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.69

-0.46

-0.23

0

Details

Expected EPS

-0.282857

Actual EPS

-0.28

Surprise EPS

0

Surprise Percent

+1.01%

Description

Tscan Therapeutics (TCRX) has reported earnings of -0.28 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.